SCHEMBL27167409

SCHEMBL27167409

COc1cc2c(O)ccnc2c(OC)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
RECQL P46063 1/20 0.35
KDM4E B2RXH2 5/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
LOX P28300 1/20 0.33
LOXL2 Q9Y4K0 1/20 0.33
NOS3 P29474 2/20 0.33
NOS1 P29475 2/20 0.33
NOS2 P35228 2/20 0.33
ERN1 O75460 2/20 0.32
HTT P42858 2/20 0.32
ALOX12 P18054 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
ALDH1A1 P00352 1/20 0.32
MAOA P21397 1/20 0.32
LRRK2 Q5S007 1/20 0.31
MEN1 O00255 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25130861 0.83 KDM4E (0.35) TDP1KDM4ENPC1RAB9AL3MBTL1
SCHEMBL27167385 0.81 CSNK2A1 (0.35) POLBTDP1RECQLKDM4EL3MBTL1
SCHEMBL27167395 0.80 PDE10A (0.34) POLBTDP1KDM4ENPC1RAB9A
SCHEMBL31700880 0.78 MTNR1A (0.37) KDM4ENPC1RAB9AL3MBTL1NOS3
SCHEMBL14361608 0.72 HTT (0.38) POLBTDP1RECQLKDM4ENPC1
SCHEMBL14361568 0.72 MEN1 (0.40) POLBTDP1KDM4ENPC1RAB9A
SCHEMBL29812260 0.70 GABRP (0.41) KDM4ELOXLOXL2NOS3NOS1
SCHEMBL14905501 0.70 GABRP (0.41) KDM4ELOXLOXL2NOS3NOS1
SCHEMBL29828708 0.69 TLR8 (0.42) KDM4ENPC1RAB9AL3MBTL1NOS3
SCHEMBL24916103 0.69 NOS3 (0.41) TDP1KDM4ENPC1RAB9AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240262822-A1 WDR5 INHIBITORS AND MODULATORS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2024-08-08 US disclosed
EP-4334305-A1 WDR5 INHIBITORS AND MODULATORS Vanderbilt University (US) 2024-03-13 EP disclosed
WO-2022236101-A1 WDR5 INHIBITORS AND MODULATORS VANDERBILT UNIVERSITY (US) 2022-11-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240262822-A1 WDR5 INHIBITORS AND MODULATORS WDR5, WDR1, WDR3 POLB 3319/4885TDP1 2322/4885RECQL 1411/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.